 |
|
|
|
|
Washington Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Vivos Inc.
| | | | | Phone: | (509) 736-4000 | | Year Established: | 2006 | | Ticker: | RDGL | | Exchange: | OTC | | Main Contact: | Michael K. Korenko, President & CEO | | | | Company Description | | Vivos, formerly Advanced Medical Isotope, has developed an Yttrium-90 based brachytherapy injectable device, for the treatment of tumors in animals (IsoPet®) and in humans (Radiogel™). Brachytherapy uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area using the company’s proprietary hydrogel formulation. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows safe delivery of higher doses needed for treating both non-resectable and radiation-resistant cancers. | |
|
|
|
|
|
|
|
